Verition Fund Management’s Aurinia Pharmaceuticals AUPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $262K | Buy |
+30,944
| New | +$262K | ﹤0.01% | 2536 |
|
|
2025
Q1 | – | Sell |
-83,812
| Closed | -$753K | – | 2638 |
|
|
2024
Q4 | $753K | Buy |
83,812
+25,294
| +43% | +$227K | ﹤0.01% | 1664 |
|
|
2024
Q3 | $429K | Buy |
58,518
+39,583
| +209% | +$290K | ﹤0.01% | 1765 |
|
|
2024
Q2 | $108K | Buy |
+18,935
| New | +$108K | ﹤0.01% | 2071 |
|
|
2023
Q3 | – | Sell |
-65,500
| Closed | -$634K | – | 1984 |
|
|
2023
Q2 | $634K | Buy |
65,500
+27,810
| +74% | +$269K | 0.01% | 952 |
|
|
2023
Q1 | $413K | Buy |
37,690
+25,000
| +197% | +$274K | 0.01% | 1244 |
|
|
2022
Q4 | $54.8K | Sell |
12,690
-1,927
| -13% | -$8.33K | ﹤0.01% | 1475 |
|
|
2022
Q3 | $110K | Sell |
14,617
-22,001
| -60% | -$166K | ﹤0.01% | 2004 |
|
|
2022
Q2 | $368K | Buy |
+36,618
| New | +$368K | 0.01% | 1560 |
|
|
2022
Q1 | – | Sell |
-180,134
| Closed | -$4.12M | – | 1920 |
|
|
2021
Q4 | $4.12M | Buy |
+180,134
| New | +$4.12M | 0.03% | 323 |
|
|
2020
Q4 | – | Sell |
-31,100
| Closed | -$458K | – | 979 |
|
|
2020
Q3 | $458K | Sell |
31,100
-62,508
| -67% | -$921K | 0.01% | 532 |
|
|
2020
Q2 | $1.52M | Buy |
93,608
+33,555
| +56% | +$545K | 0.05% | 237 |
|
|
2020
Q1 | $871K | Buy |
60,053
+13,999
| +30% | +$203K | 0.03% | 198 |
|
|
2019
Q4 | $933K | Buy |
+46,054
| New | +$933K | 0.02% | 386 |
|